|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
(none)
|
|
INDICATIONS:
|
|
Gastric hyperacidity |
|
Hyperphosphatemia |
|
Hypertension, pregnancy |
|
Hypocalcemia |
|
Hypoparathyroidism |
|
Osteoporosis |
| |
|
|
SIDE EFFECTS:
|
|
constipation |
|
eructation |
|
flatulence |
|
gastric hypersecretion |
|
hypercalcemia |
|
hypophosphatemia |
|
metabolic alkalosis |
|
milk-alkali syndrome |
|
nausea/vomiting |
|
peptic ulcer |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
breast-feeding |
|
constipation |
|
dehydration |
|
GI bleeding |
|
GI obstruction |
|
hypercalcemia |
|
ileus |
|
peptic ulcer disease |
|
pregnancy |
|
|
ADULT DOSE:
|
|
Hypocalcemia (prophylaxis or treatment)-See Calcium Carbonate Capsules.
Antacid-See Calcium Carbonate, Antacids (Oral-Local).
[Antihyperphosphatemic]-Oral, 5 to 13 grams (2 to 5.2 grams of calcium ion) a day, in divided doses with meals.
Note: Careful titration is recommended to prevent hypercalcemia, which has been reported with doses above 2 grams of calcium ion a day. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Hypocalcemia (prophylaxis)-Oral, amount based on normal daily recommended intakes:
Persons U.S. Canada
(mg) (mg)
Infants and children 400-800 250-550
Birth to 3 years of age
4 to 6 years of age 800 600
7 to 10 years of age 800 700-1100
Hypocalcemia (treatment)-Treatment dose is individualized by prescriber based on severity of deficiency. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|